Insulin resistance and renal disease.
暂无分享,去创建一个
[1] G. Chertow,et al. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. , 2005, Journal of the American Society of Nephrology : JASN.
[2] J. Schelling,et al. The metabolic syndrome as a risk factor for chronic kidney disease: more than a fat chance? , 2004, Journal of the American Society of Nephrology : JASN.
[3] Samy I McFarlane,et al. The relationship between hyperinsulinemia, hypertension and progressive renal disease. , 2004, Journal of the American Society of Nephrology : JASN.
[4] S. Bagby. Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease? , 2004, Journal of the American Society of Nephrology : JASN.
[5] R. Schall,et al. Old antihypertensives and new diabetes , 2004, Journal of hypertension.
[6] M. Woodward,et al. Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. , 2004, International journal of epidemiology.
[7] B. Goldstein,et al. Adiponectin: A novel adipokine linking adipocytes and vascular function. , 2004, The Journal of clinical endocrinology and metabolism.
[8] K. Iseki,et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. , 2004, Kidney international.
[9] Cynthia J. Girman,et al. Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.
[10] Jing Chen,et al. The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults , 2004, Annals of Internal Medicine.
[11] Bertram L Kasiske,et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.
[12] M. Stumvoll,et al. Relative importance of liver, kidney, and substrates in epinephrine-induced increased gluconeogenesis in humans. , 2003, American journal of physiology. Endocrinology and metabolism.
[13] M. Reilly,et al. The Metabolic Syndrome: More Than the Sum of Its Parts? , 2003, Circulation.
[14] E. Lonn,et al. Cardiovascular risk in patients with mild renal insufficiency. , 2003, Kidney international. Supplement.
[15] P. Whelton,et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. , 2003, Journal of the American Society of Nephrology : JASN.
[16] H. Koyama,et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. , 2002, Journal of the American Society of Nephrology : JASN.
[17] D. Matthews,et al. The assessment of insulin resistance in man , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[18] E. Ritz,et al. Altered temporal organization of plasma insulin oscillations in chronic renal failure. , 2002, The Journal of clinical endocrinology and metabolism.
[19] T. Saruta,et al. Mild renal dysfunction is associated with insulin resistance in chronic glomerulonephritis. , 2000, Clinical nephrology.
[20] S. Spaia,et al. Effect of Short-Term rHuEPO Treatment on Insulin Resistance in Haemodialysis Patients , 2000, Nephron.
[21] M. Stumvoll,et al. Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. , 1998, The Journal of clinical investigation.
[22] M. Stumvoll,et al. Human kidney and liver gluconeogenesis: evidence for organ substrate selectivity. , 1998, American journal of physiology. Endocrinology and metabolism.
[23] R. Wilkinson,et al. Insulin resistance in adult polycystic kidney disease. , 1997, Kidney international.
[24] M. Stumvoll,et al. Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine. , 1995, The Journal of clinical investigation.
[25] S. Strandgaard,et al. Insulin resistance and hyperinsulinaemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity , 1995, Diabetologia.
[26] W. Sheu,et al. Hyperparathyroidism, glucose tolerance and platelet intracellular free calcium in chronic renal failure. , 1994, The Quarterly journal of medicine.
[27] R. Converse,et al. Sympathetic overactivity in patients with chronic renal failure. , 1992, The New England journal of medicine.
[28] R. Mak,et al. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. , 1992, Kidney international.
[29] W. Guder,et al. Renal substrate metabolism. , 1986, Physiological reviews.
[30] M. Ishii,et al. Elevated plasma catecholamines in hypertensives with primary glomerular diseases. , 1983, Hypertension.
[31] R. DeFronzo,et al. Insulin resistance in uremia. , 1981, The Journal of clinical investigation.
[32] H. Bergman,et al. THE RELATIONSHIP OF KIDNEY FUNCTION TO THE GLUCOSE UTILIZATION OF THE EXTRA ABDOMINAL TISSUES , 1938 .
[33] V. Mazzaferro,et al. Nonhepatic glucose production in humans. , 2004, American journal of physiology. Endocrinology and metabolism.
[34] S. Kihara,et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. , 2002, Journal of the American Society of Nephrology : JASN.
[35] E. Bonora,et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. , 2000, Diabetes care.
[36] P. Garlick,et al. Insulin regulation of renal glucose metabolism in humans. , 1999, American journal of physiology. Endocrinology and metabolism.
[37] G. Pacini,et al. Intravenous calcitriol normalizes insulin sensitivity in uremic patients. , 1995, Kidney international.
[38] R. DeFronzo,et al. Glucose and insulin metabolism in uremia. , 1992, Nephron.